title: Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression.
abstract: Thalamic stimulation and thalamotomy for treatment of tremor due to Parkinson's disease, essential tremor, and multiple sclerosis were compared in a randomized trial. The symptomatic and functional outcome was studied after 5 years of follow-up. Sixty-eight patients were treated (45 Parkinson's disease, 13 essential tremor, 10 multiple sclerosis) by thalamotomy (n = 34) or thalamic stimulation (n = 34). After 5 years, 48 patients were available for follow-up. The primary outcome measure was change in functional status measured by the Frenchay Activities Index (FAI), scores ranging from 0 to 60. Secondary outcome measures were tremor severity, frequency of complications, and patients' assessment of the outcome. The mean difference in FAI scores between thalamic stimulation and thalamotomy was 4.4 (95% CI: 1.1-7.7) after 6 months, 3.3 (95% CI: -0.03-6.6) after 2 years and 4.0 (95% CI: 0.3-7.7) after 5 years in favor of stimulation. Tremor suppression was equally effective after both procedures, and stable in Parkinson patients. In ET and multiple sclerosis, a diminished effect of stimulation was observed in half of the patients. There were six stimulation equipment-related complications, but neurological side effects of surgery were higher after thalamotomy. Subjective outcome-assessment by the patients was more favorable in the stimulation group.
authors.affiliation: Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands. p.r.schuurman@amc.nl
authors.forename: P Richard
authors.initials: PR
authors.lastname: Schuurman
authors.forename: D Andries
authors.initials: DA
authors.lastname: Bosch
authors.forename: Maruschka P
authors.initials: MP
authors.lastname: Merkus
authors.forename: Johannes D
authors.initials: JD
authors.lastname: Speelman
mesh_terms: D000368:Aged; D046690:Deep Brain Stimulation; D020329:Essential Tremor / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000628:therapy*; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000628:therapy*; D013788:Thalamus / Q000503:physiopathology* / Q000601:surgery*